相关实验视频

Updated: Jul 25, 2025

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions

Published on: October 17, 2017

在糖尿病加速动脉样硬化中的单细胞和巨泡细胞

Jocelyn Cervantes¹, Jenny E Kanter¹

¹Department of Medicine, UW Medicine Diabetes Institute, University of Washington, Seattle, WA, United States.

Frontiers in cardiovascular medicine

|June 28, 2023

概括

糖尿病增加了动脉样硬化心血管疾病的风险. 本综述探讨了脂质载体单细胞和巨细胞如何导致糖尿病患者的风险增加.

科学领域:

心血管科学心血管科学
代谢性疾病研究研究
动脉样硬化病理生理病理学

背景情况:

糖尿病显著增加了动脉样硬化心血管疾病 (ASCVD) 的风险.
单细胞和巨细胞是动脉样硬化的发展和进展的关键参与者.
糖尿病中脂肪代谢的改变是心血管并发症的关键因素.

研究的目的:

研究单细胞和巨细胞脂质负荷在糖尿病相关的ASCVD风险中的作用.
检查糖尿病如何影响这些免疫细胞中的脂质吸收和排泄通路.
了解脱脂症,特别是富含甘油三蛋白的脂蛋白对细胞脂质积累的贡献.

主要方法:

关于糖尿病,脂质代谢和动脉样硬化中的免疫细胞功能现有文献的综述.
对调查单细胞和巨细胞脂质处理机制的研究进行分析.
对糖尿病疾病对细胞脂质谱的影响的研究进行了审查.

主要成果:

糖尿病和相关疾病会改变单细胞和巨细胞的脂质吸收和排泄通路.
糖尿病患者的巨细胞表现出增加的脂质积累.
糖尿病中含 triglyceride 丰富的脂蛋白的升高有助于单细胞中的脂质负载.

结论:

单细胞和巨细胞中的脂质负载是糖尿病中观察到的ASCVD风险增加的重要因素.
了解这些细胞脂质动态为减轻糖尿病心血管并发症提供了潜在的治疗点.
对特定脂质通路的进一步研究可以阐明驱动糖尿病相关动脉样硬化的机制.

关键词:

糖尿病糖尿病患者糖尿病患者泡细胞泡细胞是一种宏观的地平面是一个巨大的地平面单细胞 (Monocytes) 是一种单细胞.富含甘油三酸盐的脂质甲酸氨酸.

更多相关视频

Culture of Macrophage Colony-stimulating Factor Differentiated Human Monocyte-derived Macrophages

Culture of Macrophage Colony-stimulating Factor Differentiated Human Monocyte-derived Macrophages

Published on: June 30, 2016

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

相关概念视频

Inflammation

Inflammation

Atherosclerosis I: Introduction

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

Peripheral Artery Disease I: Introduction

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...